Patent · US Active

Quinazoline derivatives for the treatment of cancer diseases

US8404697B2 · kind B2 · utility

13Cited by

8References

2Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Flavio Solca · Wien, AT
Andree AMELSBERG · Southbury, US
Gerd Stehle · Heidelberg, DE
Jacobus Van Meel · Biberach, DE
Anke Baum · Alland, AT

Key dates

Filing date	Nov 9, 2006
Grant date	Mar 26, 2013
Priority date	—
Expiry date	Feb 27, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the use of quinazolines of formula (I), wherein the groups Ra to Rd have the meanings given in the claims and specification, in cancer therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.